लोड हो रहा है...

Tapentadol extended-release for treatment of chronic pain: a review

Tapentadol is a centrally acting analgesic with a dual mechanism of action of mu receptor agonism and norepinephrine reuptake inhibition. Tapentadol immediate-release is approved by the US Food and Drug Administration for the management of moderate-to-severe acute pain. It was developed to decrease...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Vadivelu, Nalini, Timchenko, Alexander, Huang, Yili, Sinatra, Raymond
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2011
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3160834/
https://ncbi.nlm.nih.gov/pubmed/21887118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S14842
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!